These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 8072199

  • 1. Recombinant human non-glycosylated granulocyte-macrophage colony-stimulating factor in allogeneic bone marrow transplantation: double-blind placebo-controlled phase III clinical trial.
    Hiraoka A, Masaoka T, Mizoguchi H, Asano S, Kodera Y, Kitamura K, Takaku F, Komemushi S.
    Jpn J Clin Oncol; 1994 Aug; 24(4):205-11. PubMed ID: 8072199
    [Abstract] [Full Text] [Related]

  • 2. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation.
    Nemunaitis J, Rosenfeld CS, Ash R, Freedman MH, Deeg HJ, Appelbaum F, Singer JW, Flomenberg N, Dalton W, Elfenbein GJ.
    Bone Marrow Transplant; 1995 Jun; 15(6):949-54. PubMed ID: 7581096
    [Abstract] [Full Text] [Related]

  • 3. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
    Greenberg P, Advani R, Keating A, Gulati SC, Nimer S, Champlin R, Karanes C, Gorin NC, Powles RL, Smith A, Lamborn K, Cuffie C.
    Bone Marrow Transplant; 1996 Dec; 18(6):1057-64. PubMed ID: 8971373
    [Abstract] [Full Text] [Related]

  • 4. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J, Terol MJ, Urbano-Ispizua A, Rovira M, Marin P, Carreras E, Batlle M, Rozman C.
    Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
    [Abstract] [Full Text] [Related]

  • 5. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates engraftment kinetics after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia.
    Madero L, Díaz MA, Ortega JJ, Olive T, Martínez A, Badell I, Muñoz A, Gómez P.
    Haematologica; 1999 Feb; 84(2):133-7. PubMed ID: 10091411
    [Abstract] [Full Text] [Related]

  • 6. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S, Bishop MR, Tarantolo S, Cowles MK, Reed E, Anderson JR, Vose JM, Bierman P, Armitage JO, Kessinger A.
    Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
    [Abstract] [Full Text] [Related]

  • 7. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F, Pession A, Zecca M, Bonetti F, Prete L, Carrà AM, Prete A, Montagna D, Comoli P, Taibi RM, Paolucci G.
    Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051
    [Abstract] [Full Text] [Related]

  • 8. Human recombinant GM-CSF in allogeneic bone marrow transplantation for leukaemia: double-blind placebo controlled trial.
    Powles R, Treleaven J, Millar J, Gordon-Smith EC, Tiley C, Findlay M, Teo C, Duncombe A, Robinson G.
    Bone Marrow Transplant; 1991 Jan; 7 Suppl 2():85-6. PubMed ID: 1878735
    [Abstract] [Full Text] [Related]

  • 9. Granulocyte colony-stimulating factor in allogeneic bone marrow transplantation.
    Kitayama H, Ishikawa J, Yamagami T, Teshima H, Hiraoka A, Nakamura H, Shibata H, Masaoka T, Ishigami S, Takaku F.
    Jpn J Clin Oncol; 1989 Dec; 19(4):367-72. PubMed ID: 2481758
    [Abstract] [Full Text] [Related]

  • 10. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 11. Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) administration after autologous bone marrow transplantation for acute myeloblastic leukemia enhances activated killer cell function and may diminish leukemic relapse.
    Richard C, Baro J, Bello-Fernandez C, Hermida G, Calavia J, Olalla I, Alsar MJ, Loyola I, Cuadrado MA, Iriondo A.
    Bone Marrow Transplant; 1995 May; 15(5):721-6. PubMed ID: 7670401
    [Abstract] [Full Text] [Related]

  • 12. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 13. Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation.
    Pene R, Appelbaum FR, Fisher L, Lilleby K, Nemunaitis J, Storb R, Buckner CD.
    Bone Marrow Transplant; 1993 Mar; 11(3):219-22. PubMed ID: 8467286
    [Abstract] [Full Text] [Related]

  • 14. [Clinical effect of recombinant human granulocyte colony-stimulating factor in bone marrow transplantation. The Japan rhG-CSF Clinical Study Group].
    Asano S, Masaoka T, Takaku F.
    Gan To Kagaku Ryoho; 1990 Jun; 17(6):1201-9. PubMed ID: 1693489
    [Abstract] [Full Text] [Related]

  • 15. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.
    J Clin Oncol; 2004 Feb 01; 22(3):416-23. PubMed ID: 14691124
    [Abstract] [Full Text] [Related]

  • 16. Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
    Joshi SS, Bishop MR, Lynch JC, Tarantolo SR, Abhyankar S, Bierman PJ, Vose JM, Geller RB, McGuirk J, Foran J, Bociek RG, Hadi A, Day SD, Armitage JO, Kessinger A, Pavletic ZS.
    Cytotherapy; 2003 Feb 01; 5(6):542-52. PubMed ID: 14660050
    [Abstract] [Full Text] [Related]

  • 17. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.
    Ozcan M, Ustün C, Akçağlayan E, Akan H, Arslan O, Ilhan O, Beksaç M, Gürman G, Demirer T, Arat M, Celebi H, Konuk N, Uysal A, Koç H.
    Bone Marrow Transplant; 2001 Mar 01; 27(5):499-505. PubMed ID: 11313683
    [Abstract] [Full Text] [Related]

  • 18. [Clinical application of recombinant human colony-stimulating factor (rhG-CSF) in bone marrow transplantation].
    Takahashi S, Kodo H.
    Rinsho Ketsueki; 1990 May 01; 31(5):589-96. PubMed ID: 1697628
    [Abstract] [Full Text] [Related]

  • 19. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT, Krog C, Stockschläder M, Schleimer B, Zeller W, Krüger W, Erttmann R, Zander AR.
    Anticancer Res; 1997 May 01; 17(1B):589-99. PubMed ID: 9066585
    [Abstract] [Full Text] [Related]

  • 20. No increase in relapse in patients with myeloid leukaemias receiving rhGM-CSF after allogeneic bone marrow transplantation.
    Gupta P, Tiley C, Powles R, Treleaven J, Millar J, Catalano J.
    Bone Marrow Transplant; 1992 Jun 01; 9(6):491-3. PubMed ID: 1628135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.